Connect with us

Technology

Docusign Announces Second Quarter Fiscal 2025 Financial Results

Published

on

SAN FRANCISCO, Sept. 5, 2024 /PRNewswire/ — Docusign, Inc. (NASDAQ: DOCU) today announced results for its fiscal quarter ended July 31, 2024. Prepared remarks and the news release with the financial results will be accessible on Docusign’s website at investor.docusign.com prior to its webcast.

“Docusign continued its evolution with improved business stability and increased efficiency, resulting in record operating profit,” said Allan Thygesen, CEO of Docusign. “We’re proud that we began shipping our Intelligent Agreement Management platform this quarter and we are encouraged by the early results and customer feedback.”

Second Quarter Financial Highlights

Total revenue was $736.0 million, an increase of 7% year-over-year. Subscription revenue was $717.4 million, an increase of 7% year-over-year. Professional services and other revenue was $18.7 million, an increase of 2% year-over-year.Billings were $724.5 million, an increase of 2% year-over-year.GAAP gross margin was 78.9% compared to 78.8% in the same period last year. Non-GAAP gross margin was 82.2% compared to 82.3% in the same period last year.GAAP net income per basic share was $4.34 on 205 million shares outstanding compared to $0.04 on 204 million shares outstanding in the same period last year.GAAP net income per diluted share was $4.26 on 208 million shares outstanding compared to $0.04 on 208 million shares outstanding in the same period last year.Non-GAAP net income per diluted share was $0.97 on 208 million shares outstanding compared to $0.72 on 208 million shares outstanding in the same period last year.Net cash provided by operating activities was $220.2 million compared to $211.0 million in the same period last year.Free cash flow was $197.9 million compared to $183.6 million in the same period last year.Cash, cash equivalents, restricted cash and investments were $1.0 billion at the end of the quarter.Repurchases of common stock were $200.1 million compared to $30.0 million in the same period last year.

A reconciliation of GAAP to non-GAAP financial measures has been provided in the tables included in this press release. An explanation of these measures is also included below under the heading “Non-GAAP Financial Measures and Other Key Metrics.”

Operational and Other Financial Highlights:

Docusign Intelligent Agreement Management (“IAM”) General Availability: Docusign announced the beginning of general availability for IAM, a new category of AI-powered cloud software that helps streamline and automate agreement processes.

IAM Release 1 Availability: IAM applications, which include IAM Core, IAM for Sales, and IAM for CX, are now generally available in the U.S. IAM for CX went live for small and medium-sized commercial customers in North America and Australia. IAM will continue to rollout to enterprise and self-service customers across additional geographies throughout the fiscal year.

Executive Appointments: Docusign announced the following new leaders:

Paula Hansen joined Docusign as President and Chief Revenue Officer, leading enterprise and commercial sales and partnership teams worldwide. Most recently, Hansen served as President and Chief Revenue Officer at Alteryx, where she was responsible for leading the global go-to-market organization, which includes worldwide sales, sales engineering, partners, marketing, customer experience, customer support and revenue operations. Prior to Alteryx, she served in senior sales roles at SAP and Cisco.Sagnik Nandy joined Docusign as Chief Technology Officer, leading all aspects of engineering, research and engineering operations. Most recently, Nandy served as President and Chief Development Officer at Okta, where he led product, engineering and design for the Workforce Identity Cloud, which includes Okta’s core identity and access management platform. Prior to Okta, he served as VP of Engineering at Google.

Guidance

The company currently expects the following guidance:

Quarter ending October 31, 2024 (in millions, except percentages):

Total revenue

$743

to

$747

Subscription revenue

$722

to

$726

Billings

$710

to

$720

Non-GAAP gross margin

81.0 %

to

82.0 %

Non-GAAP operating margin

28.5 %

to

29.5 %

Non-GAAP diluted weighted-average shares outstanding

206

to

211

 

Fiscal Year ending January 31, 2025 (in millions, except percentages):

Total revenue

$2,940

to

$2,952

Subscription revenue

$2,864

to

$2,876

Billings

$2,990

to

$3,030

Non-GAAP gross margin

81.0 %

to

82.0 %

Non-GAAP operating margin

29.0 %

to

29.5 %

Non-GAAP diluted weighted-average shares outstanding

206

to

211

A reconciliation of non-GAAP guidance measures to corresponding GAAP guidance measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty regarding, and the potential variability of, expenses that may be incurred in the future. Stock-based compensation-related charges, including employer payroll tax-related items on employee stock transactions, are impacted by many factors, including the timing of employee stock transactions, the future fair market value of our common stock, and our future hiring and retention needs, all of which are difficult to predict and subject to constant change. We have provided a reconciliation of GAAP to non-GAAP financial measures in the financial statement tables for our historical non-GAAP financial results included in this release.

Webcast Conference Call Information

The company will host a conference call on September 5, 2024 at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. A live webcast of the event will be available on the Docusign Investor Relations website at investor.docusign.com. Prepared remarks and the news release with the financial results will also be accessible on Docusign’s website prior to the webcast. A live dial-in will be available domestically at 877-407-0784 or internationally at 201-689-8560. A replay will be available domestically at 844-512-2921 or internationally at 412-317-6671 until midnight (EST) September 19, 2024 using the passcode 13748491.

About Docusign

Docusign brings agreements to life. Approximately 1.6 million customers and more than a billion people in over 180 countries use Docusign solutions to accelerate the process of doing business and simplify people’s lives. With intelligent agreement management, Docusign unleashes business critical data that is trapped inside of documents. Until now, these were disconnected from business systems of record, costing businesses time, money, and opportunity. Using Docusign IAM, companies can create, commit, and manage agreements with solutions created by the #1 company in e-signature and contract lifecycle management (CLM). Learn more at www.docusign.com.

Copyright 2024. Docusign, Inc. is the owner of DOCUSIGN® and all its other marks (www.docusign.com/IP).

Investor Relations:
Docusign Investor Relations
investors@docusign.com

Media Relations:
Docusign Corporate Communications
media@docusign.com

Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on our management’s beliefs and assumptions and on information currently available to management, and which statements involve substantial risk and uncertainties. All statements contained in this press release other than statements of historical fact, including statements regarding our future operating results and financial position, our business strategy and plans, market growth and trends, objectives for future operations, and the impact of such assumptions on our financial condition and results of operations are forward-looking statements. Forward-looking statements in this press release also include, among other things, statements under “Guidance” above and any other statements about expected financial metrics, such as revenue, billings, non-GAAP gross margin, non-GAAP operating margin, non-GAAP diluted weighted-average shares outstanding, and non-financial metrics, as well as statements related to our expectations regarding the benefits and rollout of the Docusign IAM platform. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions.

Forward-looking statements contained in this press release include, but are not limited to, statements about: our expectations regarding global macro-economic conditions, including the effects of inflation, volatile interest rates, and market volatility on the global economy; our ability to estimate the size and growth of our total addressable market; our ability to compete effectively in an evolving and competitive market; the impact of any data breaches, cyberattacks or other malicious activity on our technology systems; our ability to effectively sustain and manage our growth and future expenses and maintain or increase future profitability; our ability to attract new customers and maintain and expand our existing customer base; our ability to effectively implement and execute our restructuring plans; our ability to scale and update our platform to respond to customers’ needs and rapid technological change, including our ability to successfully incorporate generative artificial intelligence into our existing and future products; our ability to successfully execute our go-to-market and sales strategy for our IAM platform; our ability to expand use cases within existing customers and vertical solutions; our ability to expand our operations and increase adoption of our platform internationally; our ability to strengthen and foster our relationships with developers; our ability to retain our direct sales force, customer success team and strategic partnerships around the world; our ability to identify targets for and execute potential acquisitions and to successfully integrate and realize the anticipated benefits of such acquisitions; our ability to maintain, protect and enhance our brand; the sufficiency of our cash, cash equivalents and capital resources to satisfy our liquidity needs; limitations on us due to obligations we have under our credit facility or other indebtedness; our ability to realize the anticipated benefits of our stock repurchase program; our failure or the failure of our software to comply with applicable industry standards, laws and regulations; our ability to maintain, protect and enhance our intellectual property; our ability to successfully defend litigation against us; our ability to attract large organizations as users; our ability to maintain our corporate culture; our ability to offer high-quality customer support; our ability to hire, retain and motivate qualified personnel, including executive level management; our ability to successfully manage and integrate executive management transitions; uncertainties regarding the impact of general economic and market conditions, including as a result of regional and global conflicts; our ability to successfully implement and maintain new and existing information technology systems, including our ERP system; and our ability to maintain proper and effective internal controls.

Additional risks and uncertainties that could affect our financial results are included in the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K for the fiscal year ended January 31, 2024 filed on March 21, 2024, our quarterly report on Form 10-Q for the quarter ended July 31, 2024, which we expect to file on September 6, 2024 with the Securities and Exchange Commission (the “SEC”), and other filings that we make from time to time with the SEC. The forward-looking statements made in this press release relate only to events as of the date on which such statements are made. We undertake no obligation to update any forward-looking statements after the date of this press release or to conform such statements to actual results or revised expectations, except as required by law.

Non-GAAP Financial Measures and Other Key Metrics

To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we use certain non-GAAP financial measures, as described below, to understand and evaluate our core operating performance. These non-GAAP financial measures, which may be different than similarly-titled measures used by other companies, are presented to enhance investors’ overall understanding of our financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.

We believe that these non-GAAP financial measures provide useful information about our financial performance, enhance the overall understanding of our past performance and future prospects, and allow for greater transparency with respect to important metrics used by our management for financial and operational decision-making. We present these non-GAAP measures to assist investors in seeing our financial performance using a management view, and because we believe that these measures provide an additional tool for investors to use in comparing our core financial performance over multiple periods with other companies in our industry. However, these non-GAAP measures are not intended to be considered in isolation from, a substitute for, or superior to our GAAP results.

Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP income from operations, non-GAAP operating margin, non-GAAP net income and non-GAAP net income per share: We define these non-GAAP financial measures as the respective GAAP measures, excluding expenses related to stock-based compensation, employer payroll tax on employee stock transactions, amortization of acquisition-related intangibles, amortization of debt discount and issuance costs, fair value adjustments to strategic investments, acquisition-related expenses, lease-related impairment and lease-related charges, restructuring and other related charges, as these costs are not reflective of ongoing operations and, as applicable, other special items. The amount of employer payroll tax-related items on employee stock transactions is dependent on our stock price and other factors that are beyond our control and do not correlate to the operation of the business. When evaluating the performance of our business and making operating plans, we do not consider these items (for example, when considering the impact of equity award grants, we place a greater emphasis on overall stockholder dilution rather than the accounting charges associated with such grants). We believe it is useful to exclude these expenses in order to better understand the long-term performance of our core business and to facilitate comparison of our results to those of peer companies and over multiple periods. In addition to these exclusions, we subtract an assumed provision for income taxes to calculate non-GAAP net income. We utilize a fixed long-term projected tax rate in our computation of the non-GAAP income tax provision to provide better consistency across the reporting periods. For fiscal 2024 and fiscal 2025, we have determined the projected non-GAAP tax rate to be 20%.

Free cash flow: We define free cash flow as net cash provided by operating activities less purchases of property and equipment. We believe free cash flow is an important liquidity measure of the cash that is available (if any), after purchases of property and equipment, for operational expenses, investment in our business, and to make acquisitions. Free cash flow is useful to investors as a liquidity measure because it measures our ability to generate or use cash in excess of our capital investments in property and equipment. Once our business needs and obligations are met, cash can be used to maintain a strong balance sheet and invest in future growth.

Billings: We define billings as total revenues plus the change in our contract liabilities and refund liability less contract assets and unbilled accounts receivable in a given period. Billings reflects sales to new customers plus subscription renewals and additional sales to existing customers. Only amounts invoiced to a customer in a given period are included in billings. We believe billings can be used to measure our periodic performance, when taking into consideration the timing aspects of customer renewals, which represents a large component of our business. Given that most of our customers pay in annual installments one year in advance, but we typically recognize a majority of the related revenue ratably over time, we use billings to measure and monitor our ability to provide our business with the working capital generated by upfront payments from our customers.

For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measure, please see “Reconciliation of GAAP to Non-GAAP Financial Measures” below.

 

DOCUSIGN, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months Ended
July 31,

Six Months Ended
July 31,

(in thousands, except per share data)

2024

2023

2024

2023

Revenue:

Subscription

$    717,366

$    669,367

$ 1,408,849

$ 1,308,674

Professional services and other

18,661

18,320

36,818

40,401

Total revenue

736,027

687,687

1,445,667

1,349,075

Cost of revenue:

Subscription

132,372

116,185

258,974

225,127

Professional services and other

23,093

29,397

45,937

56,942

Total cost of revenue

155,465

145,582

304,911

282,069

Gross profit

580,562

542,105

1,140,756

1,067,006

Operating expenses:

Sales and marketing

287,464

294,838

569,108

575,443

Research and development

147,571

135,960

281,891

251,324

General and administrative

87,129

103,884

179,607

208,695

Restructuring and other related charges

597

811

29,721

29,583

Total operating expenses

522,761

535,493

1,060,327

1,065,045

Income from operations

57,801

6,612

80,429

1,961

Interest expense

(544)

(1,592)

(688)

(3,558)

Interest income and other income, net

14,630

17,455

28,739

29,700

Income before provision for (benefit from) income taxes

71,887

22,475

108,480

28,103

Provision for (benefit from) income taxes

(816,324)

15,080

(813,491)

20,169

Net income

$    888,211

$       7,395

$    921,971

$       7,934

Net income per share attributable to common stockholders:

Basic

$         4.34

$         0.04

$         4.49

$0.04

Diluted

$         4.26

$         0.04

$         4.40

$0.04

Weighted-average shares used in computing net income per share:

Basic

204,604

203,703

205,231

203,177

Diluted

208,274

208,192

209,559

208,284

Stock-based compensation expense included in costs and expenses:

Cost of revenue—subscription

$      15,593

$      13,081

$      29,774

$      24,438

Cost of revenue—professional services and other

4,998

7,286

9,700

14,016

Sales and marketing

58,778

51,563

105,049

96,889

Research and development

53,430

45,151

97,632

81,148

General and administrative

31,649

34,592

60,169

74,934

Restructuring and other related charges

208

34

4,836

4,988

 

DOCUSIGN, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

(in thousands)

July 31, 2024

January 31, 2024

Assets

Current assets

Cash and cash equivalents

$              619,064

$              797,060

Investments—current

319,289

248,402

Accounts receivable, net

309,885

439,299

Contract assets—current

13,449

15,922

Prepaid expenses and other current assets

81,693

66,984

Total current assets

1,343,380

1,567,667

Investments—noncurrent

102,537

121,977

Property and equipment, net

265,544

245,173

Operating lease right-of-use assets

117,877

123,188

Goodwill

455,519

353,138

Intangible assets, net

90,227

50,905

Deferred contract acquisition costs—noncurrent

427,599

409,627

Deferred tax assets—noncurrent

822,026

2,031

Other assets—noncurrent

129,232

97,584

Total assets

$           3,753,941

$           2,971,290

Liabilities and Equity

Current liabilities

Accounts payable

$                  8,116

$                19,029

Accrued expenses and other current liabilities

93,251

104,037

Accrued compensation

178,603

195,266

Contract liabilities—current

1,307,565

1,320,059

Operating lease liabilities—current

19,769

22,230

Total current liabilities

1,607,304

1,660,621

Contract liabilities—noncurrent

23,020

21,980

Operating lease liabilities—noncurrent

115,832

120,823

Deferred tax liability—noncurrent

18,122

16,795

Other liabilities—noncurrent

28,257

21,332

Total liabilities

1,792,535

1,841,551

Stockholders’ equity

Common stock

20

21

Treasury stock

(2,670)

(2,164)

Additional paid-in capital

3,087,650

2,821,461

Accumulated other comprehensive loss

(24,548)

(19,360)

Accumulated deficit

(1,099,046)

(1,670,219)

Total stockholders’ equity

1,961,406

1,129,739

Total liabilities and equity

$           3,753,941

$           2,971,290

 

DOCUSIGN, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Three Months Ended
July 31,

Six Months Ended
July 31,

(in thousands)

2024

2023

2024

2023

Cash flows from operating activities:

Net income

$   888,211

$      7,395

$   921,971

$      7,934

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

27,022

25,238

51,528

48,105

Amortization of deferred contract acquisition and fulfillment costs

57,255

50,152

111,467

98,382

Amortization of debt discount and transaction costs

139

1,249

277

2,495

Non-cash operating lease costs

4,984

5,751

9,862

11,731

Stock-based compensation expense

164,656

151,707

307,160

296,413

Deferred income taxes

(826,038)

1,797

(824,561)

3,420

Other

3,851

49

5,323

(782)

Changes in operating assets and liabilities:

Accounts receivable

(7,068)

(8,478)

123,571

99,803

Prepaid expenses and other current assets

(6)

2,383

(17,067)

(14,420)

Deferred contract acquisition and fulfillment costs

(68,183)

(56,830)

(131,255)

(113,356)

Other assets

(16,975)

(772)

(15,058)

(8,433)

Accounts payable

(10,412)

(11,273)

(11,575)

(20,294)

Accrued expenses and other liabilities

(4,680)

9,069

(8,160)

10,164

Accrued compensation

25,146

18,270

(19,902)

(3,312)

Contract liabilities

(11,553)

22,171

(16,526)

40,458

Operating lease liabilities

(6,141)

(6,862)

(12,021)

(13,657)

Net cash provided by operating activities

220,208

211,016

475,034

444,651

Cash flows from investing activities:

Cash paid for acquisition, net of acquired cash

(143,611)

(143,611)

Purchases of marketable securities

(103,603)

(120,542)

(223,241)

(174,372)

Maturities of marketable securities

93,509

83,318

175,623

164,017

Purchases of strategic and other investments

(125)

(120)

(625)

(120)

Purchases of property and equipment

(22,280)

(27,379)

(45,033)

(46,436)

Net cash used in investing activities

(176,110)

(64,723)

(236,887)

(56,911)

Cash flows from financing activities:

Repurchases of common stock

(200,076)

(30,008)

(349,138)

(70,480)

Settlement of capped calls, net of related costs

23,688

Payment of tax withholding obligation on net RSU settlement and ESPP purchase

(39,446)

(40,044)

(81,083)

(62,681)

Proceeds from exercise of stock options

454

705

1,089

832

Proceeds from employee stock purchase plan

20,190

18,390

Net cash used in financing activities

(239,068)

(69,347)

(408,942)

(90,251)

Effect of foreign exchange on cash, cash equivalents and restricted cash

238

1,279

(2,677)

2,290

Net increase (decrease) in cash, cash equivalents and restricted cash

(194,732)

78,225

(173,472)

299,779

Cash, cash equivalents and restricted cash at beginning of period (1)

822,759

944,755

801,499

723,201

Cash, cash equivalents and restricted cash at end of period (1)

$   628,027

$  1,022,980

$   628,027

$  1,022,980

(1) Cash, cash equivalents and restricted cash included restricted cash of $9.0 million and $4.4 million at July 31, 2024 and January 31, 2024.

 

DOCUSIGN, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

Reconciliation of gross profit (loss) and gross margin:

Three Months Ended
July 31,

Six Months Ended
July 31,

(in thousands)

2024

2023

2024

2023

GAAP gross profit

$   580,562

$   542,105

$  1,140,756

$  1,067,006

Add: Stock-based compensation

20,591

20,367

39,474

38,454

Add: Amortization of acquisition-related intangibles

3,067

2,314

5,137

4,717

Add: Employer payroll tax on employee stock transactions

816

713

1,839

1,387

Add: Lease-related impairment and lease-related charges

292

721

Non-GAAP gross profit

$   605,036

$   565,791

$  1,187,206

$  1,112,285

GAAP gross margin

78.9 %

78.8 %

78.9 %

79.1 %

Non-GAAP adjustments

3.3 %

3.5 %

3.1 %

3.3 %

Non-GAAP gross margin

82.2 %

82.3 %

82.0 %

82.4 %

GAAP subscription gross profit

$   584,994

$   553,182

$  1,149,875

$  1,083,547

Add: Stock-based compensation

15,593

13,081

29,774

24,438

Add: Amortization of acquisition-related intangibles

3,067

2,314

5,137

4,717

Add: Employer payroll tax on employee stock transactions

595

465

1,387

930

Add: Lease-related impairment and lease-related charges

206

505

Non-GAAP subscription gross profit

$   604,249

$   569,248

$  1,186,173

$  1,114,137

GAAP subscription gross margin

81.5 %

82.6 %

81.6 %

82.8 %

Non-GAAP adjustments

2.7 %

2.4 %

2.6 %

2.3 %

Non-GAAP subscription gross margin

84.2 %

85.0 %

84.2 %

85.1 %

GAAP professional services and other gross loss

$    (4,432)

$  (11,077)

$    (9,119)

$  (16,541)

Add: Stock-based compensation

4,998

7,286

9,700

14,016

Add: Employer payroll tax on employee stock transactions

221

248

452

457

Add: Lease-related impairment and lease-related charges

86

216

Non-GAAP professional services and other gross profit

$         787

$    (3,457)

$      1,033

$    (1,852)

GAAP professional services and other gross margin

(23.8) %

(60.4) %

(24.8) %

(40.9) %

Non-GAAP adjustments

28.0 %

41.5 %

27.6 %

36.3 %

Non-GAAP professional services and other gross margin

4.2 %

(18.9) %

2.8 %

(4.6) %

 

Reconciliation of operating expenses:

Three Months Ended
July 31,

Six Months Ended
July 31,

(in thousands)

2024

2023

2024

2023

GAAP sales and marketing

$ 287,464

$ 294,838

$ 569,108

$ 575,443

Less: Stock-based compensation

(58,778)

(51,563)

(105,049)

(96,889)

Less: Amortization of acquisition-related intangibles

(3,113)

(2,630)

(5,742)

(5,259)

Less: Employer payroll tax on employee stock transactions

(1,595)

(1,400)

(3,733)

(3,070)

Less: Lease-related impairment and lease-related charges

(815)

(2,171)

Non-GAAP sales and marketing

$ 223,978

$ 238,430

$ 454,584

$ 468,054

GAAP sales and marketing as a percentage of revenue

39.1 %

42.9 %

39.4 %

42.7 %

Non-GAAP sales and marketing as a percentage of revenue

30.4 %

34.7 %

31.4 %

34.7 %

GAAP research and development

$ 147,571

$ 135,960

$ 281,891

$ 251,324

Less: Stock-based compensation

(53,430)

(45,151)

(97,632)

(81,148)

Less: Employer payroll tax on employee stock transactions

(1,754)

(1,387)

(4,319)

(2,795)

Less: Lease-related impairment and lease-related charges

(381)

(873)

Non-GAAP research and development

$   92,387

$   89,041

$ 179,940

$ 166,508

GAAP research and development as a percentage of revenue

20.0 %

19.8 %

19.5 %

18.6 %

Non-GAAP research and development as a percentage of revenue

12.6 %

12.9 %

12.4 %

12.3 %

GAAP general and administrative

$   87,129

$ 103,884

$ 179,607

$ 208,695

Less: Stock-based compensation

(31,649)

(34,592)

(60,169)

(74,934)

Less: Employer payroll tax on employee stock transactions

(607)

(546)

(1,285)

(978)

Less: Acquisition-related expenses

(3,358)

(4,716)

Less: Lease-related impairment and lease-related charges

(296)

(695)

Non-GAAP general and administrative

$   51,515

$   68,450

$ 113,437

$ 132,088

GAAP general and administrative as a percentage of revenue

11.8 %

15.1 %

12.4 %

15.4 %

Non-GAAP general and administrative as a percentage of revenue

7.0 %

10.0 %

7.8 %

9.8 %

 

Reconciliation of income from operations and operating margin:

Three Months Ended
July 31,

Six Months Ended
July 31,

(in thousands)

2024

2023

2024

2023

GAAP income from operations

$   57,801

$    6,612

$   80,429

$    1,961

Add: Stock-based compensation

164,448

151,673

302,324

291,425

Add: Amortization of acquisition-related intangibles

6,180

4,944

10,879

9,976

Add: Employer payroll tax on employee stock transactions

4,772

4,046

11,176

8,230

Add: Acquisition-related expenses

3,358

4,716

Add: Restructuring and other related charges

597

811

29,721

29,583

Add: Lease-related impairment and lease-related charges

1,784

4,460

Non-GAAP income from operations

$ 237,156

$ 169,870

$ 439,245

$ 345,635

GAAP operating margin

7.9 %

1.0 %

5.6 %

0.1 %

Non-GAAP adjustments

24.3 %

23.7 %

24.8 %

25.5 %

Non-GAAP operating margin

32.2 %

24.7 %

30.4 %

25.6 %

 

Reconciliation of net income and net income per share, basic and diluted:

Three Months Ended
July 31,

Six Months Ended
July 31,

(in thousands, except per share data)

2024

2023

2024

2023

GAAP net income

$    888,211

$       7,395

$    921,971

$       7,934

Add: Stock-based compensation

164,448

151,673

302,324

291,425

Add: Amortization of acquisition-related intangibles

6,180

4,944

10,879

9,976

Add: Employer payroll tax on employee stock transactions

4,772

4,046

11,176

8,230

Add: Acquisition-related expenses

3,358

4,716

Add: Restructuring and other related charges

597

811

29,721

29,583

Add: Amortization of debt discount and issuance costs

1,294

2,898

Add: Fair value adjustments to strategic investments

119

Add: Lease-related impairment and lease-related charges

1,784

4,460

Add: Income tax and other tax adjustments

(866,572)

(22,325)

(906,950)

(54,790)

Non-GAAP net income

$    200,994

$    149,622

$    373,837

$    299,835

Numerator:

Non-GAAP net income

$    200,994

$    149,622

$    373,837

$    299,835

Add: Interest expense on convertible senior notes

46

403

Non-GAAP net income attributable to common stockholders, diluted

$    200,994

$    149,668

$    373,837

$    300,238

Denominator:

Weighted-average common shares outstanding, basic

204,604

203,703

205,231

203,177

Effect of dilutive securities

3,670

4,489

4,328

5,107

Non-GAAP weighted-average common shares outstanding, diluted

208,274

208,192

209,559

208,284

GAAP net income per share, basic

$         4.34

$         0.04

$         4.49

$         0.04

GAAP net income per share, diluted

$         4.26

$         0.04

$         4.40

$         0.04

Non-GAAP net income per share, basic

$         0.98

$         0.73

$         1.82

$         1.48

Non-GAAP net income per share, diluted

$         0.97

$         0.72

$         1.78

$         1.44

 

Computation of free cash flow:

Three Months Ended
July 31,

Six Months Ended
July 31,

(in thousands)

2024

2023

2024

2023

Net cash provided by operating activities

$    220,208

$    211,016

$    475,034

$    444,651

Less: Purchases of property and equipment

(22,280)

(27,379)

(45,033)

(46,436)

Non-GAAP free cash flow

$    197,928

$    183,637

$    430,001

$    398,215

Net cash used in investing activities

$  (176,110)

$    (64,723)

$  (236,887)

$    (56,911)

Net cash used in financing activities

$  (239,068)

$    (69,347)

$  (408,942)

$    (90,251)

 

Computation of billings:

Three Months Ended
July 31,

Six Months Ended
July 31,

(in thousands)

2024

2023

2024

2023

Revenue

$    736,027

$    687,687

$ 1,445,667

$ 1,349,075

Add: Contract liabilities and refund liability, end of period

1,334,461

1,233,894

1,334,461

1,233,894

Less: Contract liabilities and refund liability, beginning of period

(1,340,680)

(1,210,965)

(1,343,792)

(1,191,269)

Add: Contract assets and unbilled accounts receivable, beginning of period

17,179

22,936

20,189

16,615

Less: Contract assets and unbilled accounts receivable, end of period

(17,461)

(22,358)

(17,461)

(22,358)

Add: Contract assets and unbilled accounts receivable by acquisitions

53

53

Less: Contract liabilities and refund liability contributed by acquisitions

(5,071)

(5,071)

Non-GAAP billings

$    724,508

$    711,194

$ 1,434,046

$ 1,385,957

 

 

View original content:https://www.prnewswire.com/news-releases/docusign-announces-second-quarter-fiscal-2025-financial-results-302238864.html

SOURCE DocuSign, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Wistron Celebrates Grand Opening of First U.S. Smart Factory Marking Milestone in Global Smart Manufacturing Strategy

Published

on

By

FORT WORTH, Texas, July 21, 2026 /PRNewswire/ — Wistron Corporation (“Wistron”) celebrated the grand opening of its D1 AI smart facility in Fort Worth, Texas, the site where the first NVIDIA GB300 Grace Blackwell Ultra Superchip was built and mass-produced in the United States. The US$ 700 million facility, spanning approximately 324,000 square foot, was officially unveiled during a ceremony led by Wistron Chairman Simon Lin and NVIDIA Founder and CEO Jensen Huang. Jessica Rogers, Director of the Economic Development Department for the City of Fort Worth, and Alexander Tah-ray Yui, Taiwan’s Representative to the United States, were among the government officials and business leaders who attended, marking a milestone in the expansion of Wistron’s global footprint and advanced manufacturing capabilities.

This is a key hub in Wistron’s global AI infrastructure manufacturing network. The facility runs on NVIDIA accelerated computing and integrates NVIDIA’s Nemotron and Cosmos open frontier models and Omniverse and Metropolis libraries, using digital twin technology to optimize factory design, production workflows, and operational efficiency. It is Wistron’s first U.S.-based manufacturing facility, established to serve customers locally and produce NVIDIA’s most advanced and cutting-edge products. Wistron Chairman Simon Lin said “The operation here is not typical manufacturing. It is new, very comprehensive, and high-tech. Right now we produce the NVIDIA GB300 Grace Blackwell Ultra Superchip, and beyond, we are also going to produce the NVIDIA Vera Rubin Superchip here. In the next couple of years, this location will be one of the most important, as we build AI infrastructure here in the United States. I think this is the reason we say that there will be the next chapter, and we are going to empower AI from Texas.”

Responding to Customer Needs: Texas, the Newest Global Manufacturing Hub
At this pivotal moment for global AI infrastructure, Wistron is drawing on decades of global manufacturing experience to expand its footprint in Texas, a state with a well-established ecosystem for logistics, talent recruitment, and advanced manufacturing. The new D1 facility produces the NVIDIA GB300 Grace Blackwell Ultra Superchip and soon, the NVIDIA Vera Rubin Superchip — critical to powering the next generation of AI computing. The new Fort Worth facility strengthens a critical upstream layer of the AI infrastructure supply chain by expanding domestic capacity to assemble and test NVIDIA AI systems. These servers can be integrated into NVIDIA DSX infrastructure, with DSX providing the common architecture and technologies needed to deploy and operate energy-efficient AI factories at scale.

One-Stop Operational Ecosystem Strengthens U.S. AI Supply Chain Resilience
Behind every breakthrough in AI computing lies the manufacturing capability to scale it. Wistron is expanding its AI server production capabilities from Taiwan to the United States, guided by a vision of precision, efficiency, and sustainability. This reflects a broader industry shift: AI leadership is determined not only by technological breakthroughs, but also by the operational capability to transform innovation into high-volume production with consistent quality, supply chain resilience, and predictable delivery. By establishing AI infrastructure manufacturing capacity in the United States, Wistron is building a one-stop operational ecosystem spanning manufacturing and after-sales service — shortening delivery timelines and customer support cycles, strengthening supply chain resilience, and laying the foundation for long-term competitive advantage as AI infrastructure continues to scale.

Partnering with NVIDIA to Pioneer a New Model for Smart Manufacturing and Energy Optimization
As the era of physical AI begins, Wistron is extending its smart manufacturing capabilities to the United States, creating a new model for AI infrastructure production built on digital manufacturing, energy optimization, and local operations. Jensen Huang said: “The largest infrastructure buildout in history is underway. Demand for AI factories—the engine of this next industrial revolution—is incredible, and they must be produced everywhere. Together, NVIDIA and Wistron are restoring US advanced manufacturing capacity in Texas, creating skilled jobs and strengthening America’s AI supply chain.” As demand for advanced manufacturing grows in Texas, smarter planning of production loads and energy use will give the plant greater control and flexibility over its electricity needs.

Turning Global Experience into Scalable AI Infrastructure
Simon Lin stressed that the speed the AI era demands comes with its own responsibility. “In the AI era, the pressure of speed is also a form of responsibility,” Lin said. “We don’t just need to build fast; we need to build right.”

The Fort Worth plant will serve as the core engine of Wistron’s U.S. manufacturing operations, the company said, connecting its global production network with ecosystem partners as it scales advanced AI manufacturing. Wistron said that the investment reflects efforts to deepen its technical capabilities, strengthen the resilience and efficiency of global supply chains, and support the next phase of AI infrastructure development.

About Wistron:
Wistron Corporation is a leading global technology service provider delivering advanced ICT products, AI infrastructure, and manufacturing solutions to technology brands worldwide. With more than 63,000 employees across North America, Europe, and Asia, Wistron continues to expand its AI, cloud, and advanced manufacturing capabilities to support the next generation of intelligent computing. For more information about Wistron, please visit the official website at www.wistron.com. Additional information about the event is available on the event website.

Media Contact:
Joyce WL Chou
joyce_wl_chou@wistron.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wistron-celebrates-grand-opening-of-first-us-smart-factory-marking-milestone-in-global-smart-manufacturing-strategy-302831439.html

SOURCE Wistron Corporation

Continue Reading

Technology

NSG Bio Accelerates Breakthrough Biotech Innovation in Singapore

Published

on

By

New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care

SINGAPORE, July 22, 2026 /PRNewswire/ — The NSG Bio Tomorrow initiative aims at supporting emerging life sciences startups working on complex challenges in respiratory and neonatal care.

Launched through the support of Chiesi Group, The Impulse initiative will provide a selected startup with one year of NSG Bio membership and access to a dedicated laboratory bench at NSG Bio Singapore. The initiative is designed to help early-stage biotech companies move from promising science toward stronger proof-of-concept work in a fully equipped research environment.

The initiative comes at a time when the biotech industry is increasingly looking for faster, more connected ways to move high-potential science from the lab toward real-world patient impact. For startups, access to infrastructure is only one part of the challenge. Equally important are the right networks, industry visibility, technical environment, and opportunities to engage with partners who understand the path from early discovery to clinical relevance.

The programme will focus on startups developing innovative biotechnological solutions with potential relevance to chronic respiratory diseases and neonatal conditions. Areas of interest include cell therapies, gene therapies, gene-editing technologies, regenerative tissue engineering, engineered or programmable living systems, lung-targeted delivery platforms, preventive approaches, and small-molecule-based approaches.

The selected startup will gain access to NSG Bio’s laboratory infrastructure, shared workspaces, meeting facilities, and wider community of biotech entrepreneurs, researchers, scientific leaders, and industry partners. The support is intended to help the company advance key research milestones while becoming part of Singapore’s growing life-science innovation ecosystem.

For NSG Bio, the initiative is part of NSG Bio Tomorrow, its ecosystem-building arm created to expand the company’s role beyond facilities and real estate. While NSG Bio is known for providing high-quality laboratory and office infrastructure for biotech companies, NSG Bio Tomorrow focuses on building the programmes, partnerships, and opportunities that help startups grow.

“Biotech companies need more than lab space. They need access, momentum, and the right ecosystem around them,” said Hasyim Sim, Co-Founder and Chief Operating Officer, NSG Bio. “Through NSG Bio Tomorrow, we are building initiatives that help promising startups connect with partners, unlock opportunities, and move their science forward. This initiative reflects exactly the kind of role we want to play in the biotech ecosystem.”

“Chiesi is committed to supporting innovation that can make a meaningful difference for patients, and we work with entrepreneurs, researchers and partners to advance meaningful ideas,” said Fabrizio Conicella, Vice President, Center of Open Innovation & Competence at Chiesi Group. “By supporting this NSG Bio Tomorrow initiative, we want to create an opportunity for early-stage innovators to access the infrastructure and ecosystem support needed to develop impactful science in respiratory and neonatal care.”

NSG Bio Tomorrow programme also reinforces Singapore’s position as a growing hub for biotech innovation in Asia, where startups, research institutions, investors, and industry partners are increasingly coming together to support the next generation of healthcare companies.

Applications open on 22 July 2026 at 09:00 a.m. SGT. Finalists will be invited to present at a virtual pitch event, after which the selected startup will be announced.

About NSG Bio

NSG Bio is Singapore’s leading provider of BSL-2 certified co-working laboratory and office spaces, supporting life-science companies from early research through growth. Through its facilities, community, and ecosystem initiatives, NSG Bio enables biotech innovators to accelerate research, access networks, and build companies that address critical healthcare challenges.

About NSG Bio Tomorrow

NSG Bio Tomorrow is NSG Bio’s ecosystem-building arm, created to support the next generation of biotech innovation through partnerships, programmes, community initiatives, and opportunities that extend beyond physical laboratory infrastructure. Its mission is to strengthen the biotech industry by connecting startups with the resources, expertise, and networks they need to thrive.

About Chiesi Group 

Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact. 

With 90 years of experience, Chiesi is headquartered in Parma (Italy), with 31 affiliates worldwide, and counts more than 7,900 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. For further information please visit https://www.chiesi.com/en/home 

Media Contact
Giridharan
Laboratory Manager
NSG Bio
giridharan@nsgbio.com
87797175

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/nsg-bio-accelerates-breakthrough-biotech-innovation-in-singapore-302830494.html

SOURCE NSG Bio

Continue Reading

Technology

House Judiciary Committee Passes Bill that Would Prevent Future Immigration Crises: Swift Action Needed by Full House, Says FAIR

Published

on

By

WASHINGTON, July 21, 2026 /PRNewswire/ — Today, the House Judiciary Committee passed an updated version of H.R. 2, the landmark border security bill from last congressional session. The bill now awaits consideration by the full House of Representatives. The Federation for American Immigration Reform (FAIR) urges Speaker Mike Johnson to schedule a final floor vote as soon as possible.

The Secure Border Act systematically closes the loopholes that allowed the Biden administration to unleash the largest and most damaging wave of illegal immigration in American history. Enactment of this legislation would prevent future anti-borders administrations from shirking their responsibilities to secure our borders and enforce our immigration laws; asserting unlimited discretion to parole inadmissible aliens to enter the country; or releasing millions of illegal aliens into the country, rather than detaining them or returning them to the country from which they entered.

“We congratulate the Judiciary Committee for its swift action on this critical legislation,” said Dale Wilcox, executive director and general counsel of FAIR. “Ending border chaos and rampant illegal immigration was a key reason that Republicans regained control of the White House and both chambers of Congress in the last election. The clock is ticking on the 119th Congress, and Republicans only have a short time to deliver on the promises they made to voters in 2024, before the midterms.

“Right now, our immigration laws are being enforced in the interests of the American people. As the last administration demonstrated, enforcement of those laws is not guaranteed unless Congress acts to prevent similar abuse in the future. Now is the time for decisive action in the House, where this bill can be passed with a simple majority vote, and an opportunity for Senate Majority Leader John Thune to put every member of that body on record before voters go to the polls in the fall,” Wilcox concluded.

Hayley Hill, hhill@fairus.org 202-328-7004

View original content to download multimedia:https://www.prnewswire.com/news-releases/house-judiciary-committee-passes-bill-that-would-prevent-future-immigration-crises-swift-action-needed-by-full-house-says-fair-302831443.html

SOURCE Federation for American Immigration Reform (FAIR)

Continue Reading

Trending